{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:07:11Z","timestamp":1790683631186,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ajoc.2024.102131","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T18:26:24Z","timestamp":1722018384000},"page":"102131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity"],"prefix":"10.1016","volume":"36","author":[{"given":"Anthony A.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5512-0929","authenticated-orcid":false,"given":"Jacob S.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette L.","family":"Giangiacomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Costakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2024.102131_bib1","unstructured":"Brown, A.C. and K. Nwanyanwu, Retinopathy of prematurity, in StatPearls. 2023, StatPearls Publishing Copyright \u00a9 2023, StatPearls Publishing LLC.: Treasure Island (FL)."},{"issue":"1","key":"10.1016\/j.ajoc.2024.102131_bib2","first-page":"Cd009734","article-title":"Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity","volume":"1","author":"Sankar","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ajoc.2024.102131_bib3","first-page":"18","article-title":"The features development and clinical course of primary congenital glacucoma in infants","volume":"4","author":"Zertsalova","year":"2013","journal-title":"Pediatrician"},{"key":"10.1016\/j.ajoc.2024.102131_bib4","article-title":"Becker-Shaffer's diagnosis and therapy of the glaucomas","volume":"vol. 1","author":"Stamper","year":"2009"},{"key":"10.1016\/j.ajoc.2024.102131_bib5","series-title":"9th Consensus Meeting","first-page":"239","author":"Consensus","year":"2013"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102131_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5115\/acb.2013.46.1.49","article-title":"Qualitative changes in fetal trabecular meshwork fibers at the human iridocorneal angle","volume":"46","author":"Hosaka","year":"2013","journal-title":"Anat Cell Biol"},{"key":"10.1016\/j.ajoc.2024.102131_bib7","first-page":"458","article-title":"The development of the trabecular meshwork and its abnormality in primary infantile glaucoma","volume":"79","author":"Anderson","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"9","key":"10.1016\/j.ajoc.2024.102131_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238633","article-title":"Management outcomes of secondary glaucoma due to retinopathy of prematurity: a 19-year prospective study at a tertiary eye care Institute. The Indian Twin cities ROP Screening (ITCROPS) database report number 8","volume":"15","author":"Senthil","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ajoc.2024.102131_bib9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0002-9394(80)90282-2","article-title":"Secondary angle-closure glaucoma in cicatricial retrolental fibroplasia","volume":"89","author":"Pollard","year":"1980","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102131_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000309868","article-title":"Angle-closure glaucoma with pupillary block mechanism in cicatricial retinopathy of prematurity","volume":"196","author":"Ueda","year":"1988","journal-title":"Ophthalmologica"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102131_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archopht.1984.01040030289020","article-title":"Angle-closure glaucoma in adults with cicatricial retinopathy of prematurity","volume":"102","author":"Smith","year":"1984","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102131_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0002-9394(82)90356-7","article-title":"Medical treatment of glaucoma associated with cicatricial retinopathy of prematurity","volume":"94","author":"Kushner","year":"1982","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajoc.2024.102131_bib13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaapos.2012.06.011","article-title":"Glaucoma in the early treatment for retinopathy of prematurity (ETROP) study","volume":"16","author":"Bremer","year":"2012","journal-title":"J aapos"},{"issue":"8","key":"10.1016\/j.ajoc.2024.102131_bib14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/bjo.2003.037994","article-title":"Angle closure glaucoma after laser photocoagulation for retinopathy of prematurity","volume":"88","author":"Uehara","year":"2004","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102131_bib15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaapos.2004.10.007","article-title":"Case series of angle-closure glaucoma after laser treatment for retinopathy of prematurity","volume":"9","author":"Trigler","year":"2005","journal-title":"J aapos"},{"issue":"6","key":"10.1016\/j.ajoc.2024.102131_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1091-8531(98)90042-8","article-title":"Angle-closure glaucoma after laser treatment for retinopathy of prematurity","volume":"2","author":"Lee","year":"1998","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.ajoc.2024.102131_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.786327","article-title":"Case report: glaucoma in an infant with retinopathy of prematurity","volume":"9","author":"Lenis","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ajoc.2024.102131_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/bs.pbr.2015.06.005","article-title":"Primary congenital glaucoma","volume":"221","author":"Ko","year":"2015","journal-title":"Prog Brain Res"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102131_bib19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0161-6420(90)32637-4","article-title":"Anterior segment evaluation of infants with retinopathy of prematurity","volume":"97","author":"Hartnett","year":"1990","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajoc.2024.102131_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/pr.2015.15","article-title":"VEGF mRNA and protein concentrations in the developing human eye","volume":"77","author":"Ma","year":"2015","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102131_bib21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/dvdy.23743","article-title":"VEGF 165 b in the developing vasculatures of the fetal human eye","volume":"241","author":"Baba","year":"2012","journal-title":"Dev Dynam"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102131_bib22","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41598-021-04616-7","article-title":"Ophthalmic complications in retinopathy of prematurity in the first decade of life in Korea using the national health insurance database","volume":"12","author":"Hong","year":"2022","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.ajoc.2024.102131_bib23","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/archopht.125.9.1276","article-title":"Evaluating the cryotherapy for retinopathy of prematurity study (CRYO-ROP)","volume":"125","author":"Mills","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajoc.2024.102131_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.884608","article-title":"Intravitreal anti-vascular endothelial growth factor injection for retinopathy of prematurity: a systematic review and meta-analysis","volume":"9","author":"Taher","year":"2022","journal-title":"Front Med"},{"issue":"7","key":"10.1016\/j.ajoc.2024.102131_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102131_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joco.2018.10.008","article-title":"Comparison of intravitreal bevacizumab injection and laser photocoagulation for type 1 zone II retinopathy of prematurity","volume":"31","author":"Roohipoor","year":"2019","journal-title":"J Curr Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102131_bib27","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s10792-022-02480-6","article-title":"Comparison of adverse events between intravitreal anti-VEGF and laser photocoagulation for treatment-requiring retinopathy of prematurity: a systematic review","volume":"43","author":"Tsiropoulos","year":"2023","journal-title":"Int Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2024.102131_bib28","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1111\/aos.13008","article-title":"Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity","volume":"94","author":"Karkhaneh","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2024.102131_bib29","first-page":"29","article-title":"[Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results]","volume":"68","author":"Autrata","year":"2012","journal-title":"Ceska a Slov Oftalmol"},{"issue":"12","key":"10.1016\/j.ajoc.2024.102131_bib30","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/IJG.0000000000001894","article-title":"Intraocular pressure elevation following intravitreal anti-VEGF injections: short- and long-term considerations","volume":"30","author":"Levin","year":"2021","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajoc.2024.102131_bib31","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.2147\/OPTH.S229708","article-title":"Short-term changes in intraocular pressure after intravitreal injection of bevacizumab for the treatment of retinopathy of prematurity","volume":"13","author":"Obata","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2024.102131_bib32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s10384-019-00661-y","article-title":"Short-term intraocular pressure changes after intravitreal injection of bevacizumab for retinopathy of prematurity","volume":"63","author":"Kato","year":"2019","journal-title":"Jpn J Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624001415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993624001415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T04:38:21Z","timestamp":1737693501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993624001415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":32,"alternative-id":["S2451993624001415"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102131","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary glaucoma after bevacizumab injection in Type-1 retinopathy of prematurity","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2024.102131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102131"}}